Home » NOVARTIS GETS EU APPROVAL FOR PROMISING EXJADE
NOVARTIS GETS EU APPROVAL FOR PROMISING EXJADE
August 31, 2006
Swiss pharmaceutical company Novartis AG Wednesday said it received European Union approval to sell Exjade, a treatment for people with excess iron in their bloodstream. Easy Bourse (http://www.easybourse.com/Website/dynamic/News.php?NewsID=48188&lang=fra&NewsRubrique=2)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct